Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults

This publication has 19 references indexed in Scilit:

• Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients
  Pediatrics, 2005
• Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis
  Vaccine, 2005
• MeNZB™: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain
  Vaccine, 2005
• Expression of Heterologous Antigens in Commensal Neisseria spp.: Preservation of Conformational Epitopes with Vaccine Potential
  Infection and Immunity, 2004
• Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B
  Journal of Pharmaceutical Sciences, 2004
• ConformationalEpitopes Recognized by Protective Anti-Neisserial Surface Protein AAntibodies
  Infection and Immunity, 2003
• Crystal Structure of Neisserial Surface Protein A (NspA), a Conserved Outer Membrane Protein with Vaccine Potential
  Journal of Biological Chemistry, 2003
• Analysis of Meningococcal Serogroup C-Specific Antibody Levels in British Columbian Children and Adolescents
  The Journal of Infectious Diseases, 1996
• Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C
  Vaccine, 1992
• HUMAN IMMUNITY TO THE MENINGOCOCCUS
  The Journal of Experimental Medicine, 1969